ACOTEC SCIEN.H. DL-00001
Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with… Read more
ACOTEC SCIEN.H. DL-00001 (7W3) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ACOTEC SCIEN.H. DL-00001 (7W3) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ACOTEC SCIEN.H. DL-00001 - Net Assets Trend (None–None)
This chart illustrates how ACOTEC SCIEN.H. DL-00001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ACOTEC SCIEN.H. DL-00001 (None–None)
The table below shows the annual net assets of ACOTEC SCIEN.H. DL-00001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ACOTEC SCIEN.H. DL-00001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ACOTEC SCIEN.H. DL-00001 Competitors by Market Cap
The table below lists competitors of ACOTEC SCIEN.H. DL-00001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ffbw Inc
OTCQX:FFBW
|
$62.34 Million |
|
Westag & Getalit ST O.N.
F:WUG
|
$62.35 Million |
|
Xtract One Technologies Inc.
OTCQX:XTRAF
|
$62.35 Million |
|
NCT Alliance Bhd
KLSE:0056
|
$62.35 Million |
|
OUE Limited
F:OUE1
|
$62.34 Million |
|
Feature Integration Technology Inc.
TWO:4951
|
$62.33 Million |
|
Federal-Mogul Goetze (India) Limited.
NSE:FMGOETZE
|
$62.33 Million |
|
Leap Therapeutics Inc
NASDAQ:LPTX
|
$62.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ACOTEC SCIEN.H. DL-00001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ACOTEC SCIEN.H. DL-00001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ACOTEC SCIEN.H. DL-00001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ACOTEC SCIEN.H. DL-00001's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ACOTEC SCIEN.H. DL-00001 (7W3) | €- | N/A | N/A | $62.34 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |